Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University College Cork
M.D. Anderson Cancer Center
Institute of Oncology Ljubljana
Emory University
M.D. Anderson Cancer Center
RenJi Hospital
The First Affiliated Hospital of Zhengzhou University
Lille Catholic University
The Netherlands Cancer Institute
University Hospital, Toulouse
Heinrich-Heine University, Duesseldorf
M.D. Anderson Cancer Center
The Methodist Hospital Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Cedars-Sinai Medical Center
Ottawa Hospital Research Institute
Shanghai Junshi Bioscience Co., Ltd.
M.D. Anderson Cancer Center
Tongji Hospital
Royal Marsden NHS Foundation Trust
Jules Bordet Institute
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Changhai Hospital
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Icahn School of Medicine at Mount Sinai
University Hospital Freiburg
University Hospital Southampton NHS Foundation Trust
M.D. Anderson Cancer Center
University of Alberta
Nouvelle Clinique Bonnefon
Medipol University
Centre Hospitalier Universitaire de Tivoli
Seoul National University Bundang Hospital
Herlev and Gentofte Hospital
Seoul National University Bundang Hospital
University of California, San Francisco
Bozyaka Training and Research Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
RenJi Hospital
Institut Paoli-Calmettes
M.D. Anderson Cancer Center
Herlev and Gentofte Hospital
Stanford University
Stanford University
Tata Memorial Centre
Chinese University of Hong Kong
M.D. Anderson Cancer Center